Pomerantz Law Firm Investigates Claims on Behalf of Investors of Metropolitan Health Networks, Inc.
Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Metropolitan Health Networks, Inc. (“Metropolitan Health” or the “Company”) (NYSE: MDF) (ISIN: US5921421039) concerning the proposed acquisition of Metropolitan Health by Humana Inc. in a cash transaction valued at approximately $850 million.
The investigation concerns whether the Metropolitan Health directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, Metropolitan Health shareholders would receive $11.25 in cash for each share of Metropolitan Health common stock. However, at least one analyst set a target price for Metropolitan Health of $13.00 per share. The proposed acquisition also represents a mere 3.7% premium over Metropolitan Health's closing price as of November 2, 2012, the last day of trading before the proposed acquisition was announced.
Metropolitan Health shareholders seeking more information about this acquisition are advised to contact Samuel J. Adams at email@example.com or 212-661-1100 or 888-476-6529, ext. 300.
The Pomerantz Firm, with offices in New York, Chicago and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.
Pomerantz Grossman Hufford Dahlstrom & Gross LLP
Samuel J. Adams
212-661-1100 ext. 300